Jake Fillery is an Evergreen Editor for Game Rant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

Rei is an Editor for GameRant's Evergreen and Features teams from Kashmir, situated in Beirut. He's an avid fan of anime, manga, and gaming. He is the author of some of the articles here that you ...

For some science fiction fans, this Thanksgiving not only marked a celebration of fall food and turkey. The holiday coincided this year with the release of the first part of "Stranger Things" Season 5 ...

We're more than a little obsessed with Stranger Things, and while we're sad we've reached the final season we are sooo excited to see how the show will come to an end. Season five, part one dropped ...

The Batman 2 has once again been delayed by a year and will now be released in theaters on October 1, 2027. Matt Reeves' sequel to 2022's The Batman was originally set to arrive in theaters in October ...

The second batch of "Stranger Things 5" episodes will be released on Christmas Day, Dec. 25. The final episode of the season is scheduled to release on New Year's Eve, Dec. 31. New episodes will be ...

Related reads:Scarlett Johansson Reportedly in Talks to Join The Batman Part 2 in Mystery Role Director Matt Reeves’ The Batman – Part II is moving forward after a long wait. The sequel had already ...

We're here to breakdown The Last of Us 2 ending, which focuses on the fates of the main characters, with questions left about Ellie, Joel, Abby, and Lev's futures. While it isn't as ambiguous as the ...

Still no word on when Demon Slayer: Infinity Castle 2 is coming to our screens, but there's plenty of hype and speculation surrounding the middle instalment in the series-ending trilogy. But other ...

Evidence-based recommendations on dostarlimab (Jemperli) with platinum-containing chemotherapy for primary advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair ...

Suggested remit: To appraise the clinical and cost effectiveness of givinostat within its marketing authorisation for treating Duchenne muscular dystrophy in people 6 years and over. Anticipate the ...